Hudson Bay Capital Management
RVPHW

Hudson Bay Capital Management’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Hudson Bay Capital Management’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-713,900
Closed -$64K – 555
2020
Q1 		$64K Buy
713,900
+701,900
+5,849% +$105K ﹤0.01% 440
2019
Q4 		$2K Buy
+12,000
New +$2.75K ﹤0.01% 416

Other funds holding RVPHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Hudson Bay Capital Management's RVPHW Position: Q2 2020 in Review

Hudson Bay Capital Management sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q2 2020, closing a stake of 713,900 shares — an estimated $64K sold.

Hudson Bay Capital Management first reported a position in RVPHW in Q4 2019 and held it in 2 quarters. The position peaked at $64K in Q1 2020. 17 funds tracked by Wall St. Rank hold RVPHW as of Q2 2020.

  • Hudson Bay Capital Management reported no remaining Reviva Pharmaceuticals Warrants position as of Q2 2020 after selling out during the quarter.
  • Hudson Bay Capital Management sold 713,900 Reviva Pharmaceuticals Warrants shares in Q2 2020, an estimated $64K.
  • Hudson Bay Capital Management first reported a position in Reviva Pharmaceuticals Warrants in Q4 2019 and held it in 2 quarters.
  • Hudson Bay Capital Management's Reviva Pharmaceuticals Warrants position peaked at $64K in Q1 2020.
  • 17 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q2 2020.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.